Medtronic (NYSE:MDT) landed both CE Mark approval in Europe and FDA 510(k) clearance in the U.S. for its Reveal LINQ insertable cardiac monitor this week.
The Reveal monitor uses the Carelink network to allow physicians to monitor patients from afar. The device is "80% smaller than other ICMs" with a profile about one-third the size of an AAA battery, Medtronic said.
This video shows the LINQ in action.